Vg Life Sciences Stock Today
| VGLS Stock | USD 0.0001 0.00 0.00% |
Performance22 of 100
| Odds Of DistressLess than 32
|
Vg Life is selling for under 1.0E-4 as of the 26th of November 2024; that is No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Vg Life has about a 32 percent probability of financial distress in the next few years of operation but had a somewhat solid performance during the last 90 days. Equity ratings for Vg Life Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of August 2024 and ending today, the 26th of November 2024. Click here to learn more.
VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd. The company has 107.88 M outstanding shares. More on Vg Life Sciences
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
VGLS Pink Sheet Highlights
| Chairman | Haig Keledjian |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Vg Life Sciences [VGLS] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vg Life's market, we take the total number of its shares issued and multiply it by Vg Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Vg Life Sciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 107.88 M outstanding shares.
Vg Life Sciences currently holds about 22.92 K in cash with (1.91 M) of positive cash flow from operations.
Check Vg Life Probability Of Bankruptcy
VGLS Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Vg Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Additional Tools for VGLS Pink Sheet Analysis
When running Vg Life's price analysis, check to measure Vg Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vg Life is operating at the current time. Most of Vg Life's value examination focuses on studying past and present price action to predict the probability of Vg Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vg Life's price. Additionally, you may evaluate how the addition of Vg Life to your portfolios can decrease your overall portfolio volatility.